Oculus VisionTech, Inc.
Oculus VisionTech, Inc. (OVTZ) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Oculus VisionTech, Inc. (OVTZ), covering cash flow, earnings, and balance sheets.
Oculus VisionTech, Inc. (OVTZ) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Oculus VisionTech, Inc. OVTZ financial performance.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| R&D Expenses | $740.00 | $1455.00 | $2551.00 | $2180.00 |
| SG&A Expenses | $94710.00 | $67886.00 | $78091.00 | $82076.00 |
| Operating Expenses | $95450.00 | $69341.00 | $80642.00 | $84256.00 |
| Total Costs & Expenses | $95450.00 | $69341.00 | $80643.00 | $84256.00 |
| Interest Income | $20.00 | $198.00 | $0.00 | $1440.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $0.00 | $0.00 | $0.00 | $43276.00 |
| EBITDA | -$95450.00 | -$69341.00 | -$80642.00 | -$84256.00 |
| EBITDA Ratio | ||||
| Operating Income | -$95450.00 | -$69341.00 | -$80643.00 | -$84256.00 |
| Operating Income Ratio | ||||
| Other Income/Expenses (Net) | $20.00 | $198.00 | $673.00 | $1440.00 |
| Income Before Tax | -$95430.00 | -$69143.00 | -$79970.00 | -$82816.00 |
| Income Before Tax Ratio | ||||
| Income Tax Expense | $0.00 | $0.00 | $0.00 | -$43276.00 |
| Net Income | -$95430.00 | -$69143.00 | -$79971.00 | -$82816.00 |
| Net Income Ratio | ||||
| EPS | -$0.001 | $0.00 | -$0.001 | -$0.001 |
| Diluted EPS | -$0.001 | $0.00 | -$0.001 | -$0.001 |
| Weighted Avg Shares Outstanding | $91.50M | $0.00 | $91.50M | $91.42M |
| Weighted Avg Shares Outstanding (Diluted) | $91.42M | $0.00 | $91.42M | $91.42M |
Over the past four quarters, Oculus VisionTech, Inc. demonstrated steady revenue growth, increasing from $0.00 in Q1 2024 to $0.00 in Q4 2024. Operating income reached -$95450.00 in Q4 2024, maintaining a consistent N/A margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at -$95450.00, reflecting operational efficiency. Net income dropped to -$95430.00, with EPS at -$0.001. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan